| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 17 |
| 1 | PRAMIPEXOLE | 17 |
| 2 | LEVODOPA | 15 |
| 3 | ARIPIPRAZOLE ORAL | 10 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 10 |
| 5 | RASAGILINE MESYLATE | 10 |
| 6 | RISPERIDONE | 10 |
| 7 | OLANZAPINE | 9 |
| 8 | PRAMIPEXOLE DIHYDROCHLORIDE | 8 |
| 9 | RASAGILINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAMIPEXOLE DIHYDROCHLORIDE | 8 | 0.0016 |
| 1 | PRAMIPEXOLE | 17 | 0.0011 |
| 2 | RASAGILINE MESYLATE | 10 | 0.0009 |
| 3 | HYDROXOCOBALAMIN | 3 | 0.0007 |
| 4 | CABERGOLINE | 2 | 0.0004 |
| 5 | AMANTADINE HYDROCHLORIDE | 2 | 0.0004 |
| 6 | ROPINIROLE | 6 | 0.0004 |
| 7 | CALCIUM POLYCARBOPHIL | 1 | 0.0003 |
| 8 | SELEGILINE | 1 | 0.0003 |
| 9 | CARBIDOPA LEVODOPA | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 26 |
| 1 | Aromatic Amino Acid [EPC] | 17 |
| 2 | Benzodiazepine [EPC] | 13 |
| 3 | Nonergot Dopamine Agonist [EPC] | 6 |
| 4 | Platinum-based Drug [EPC] | 6 |
| 5 | Typical Antipsychotic [EPC] | 6 |
| 6 | Factor Xa Inhibitor [EPC] | 4 |
| 7 | Janus Kinase Inhibitor [EPC] | 4 |
| 8 | Kinase Inhibitor [EPC] | 4 |
| 9 | Antidote [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 1 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Aromatic Amino Acid [EPC] | 17 | 0.0003 |
| 4 | Typical Antipsychotic [EPC] | 6 | 0.0002 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 3 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Atypical Antipsychotic [EPC] | 26 | 0.0001 |